50. Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake – The importance of chirality and ring size of cyclic amines

Jaunsleine, K.; Supe, L.; Spura, J.; van Beek, S.; Sandström, A.; Olsen, J.; Halleskog, C.; Bengtsson, T.; Mutule, I.; Pelcman, B. Bioorganic & Medicinal Chemistry Letters 2024, 97, 129562. DOI: 10.1016/j.bmcl.2023.129562.

 

Abstract

β2-Adrenergic receptor (β2AR) agonists have been reported to stimulate glucose uptake (GU) by skeletal muscle cells and are therefore highly interesting as a possible treatment for type 2 diabetes (T2D). The chirality of compounds often has a great impact on the activity of β2AR agonists, although this has thus far not been investigated for GU. Here we report the GU for a selection of synthesized acyclic and cyclic β-hydroxy-3-fluorophenethylamines. For the N-butyl and the N-(2-pentyl) compounds, the (R) and (R,R) (3d and 7e) stereoisomers induced the highest GU. When the compounds contained a saturated nitrogen containing 4- to 7-membered heterocycle, the (R,R,R) enantiomer of the azetidine (8a) and the pyrrolidine (9a) had the highest activity. Altogether, these results provide pivotal information for designing novel β2AR agonist for the treatment of T2D.


Date: Jan 5, 2024
AUTHOR: Viktorija Vitkovska
Publications